Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Feb 17, 2026 · 10-Q · 48 days after period end · 0001477932-26-000862
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$297.59K | -$417.27K | -$1.20M | -$1.29M |
| EPS Diluted | $0.00 | $0.00 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 17, 2026 · 48 d after period end
